Cheung Labs positioning Microfocus BPH system as low-cost microwave therapy device.
This article was originally published in The Gray Sheet
CHEUNG LABS POSITIONING MICROFOCUS BPH AS LOW-COST 39424ALTERNATIVE to EDAP Technomed's Prostatron microwave treatment for benign prostatic hyperplasia. At $50,000-$75,000, Cheung's microwave system "is marketed in a much more competitive price range" than the Prostatron, which is said to be priced at several hundred thousand dollars.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.